Max Healthcare Institute 過去の業績

過去基準チェック /26

Max Healthcare Instituteは、平均年間49.2%の収益成長を遂げていますが、 Healthcare業界の収益は、年間成長しています。収益は、平均年間23.2% 26.1%収益成長率で成長しています。 Max Healthcare Instituteの自己資本利益率は12%であり、純利益率は17.6%です。

主要情報

49.2%

収益成長率

46.0%

EPS成長率

Healthcare 業界の成長	29.4%
収益成長率	26.1%
株主資本利益率	12.0%
ネット・マージン	17.6%
次回の業績アップデート	30 Jan 2025

Recent updates

収支内訳

Max Healthcare Institute の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

BSE:543220 収益、費用、利益 ( )INR Millions
日付	収益	収益	G+A経費
30 Sep 24	60,083	10,590	12,508
30 Jun 24	56,640	10,538	11,734
31 Mar 24	54,060	10,576	11,169
31 Dec 23	51,976	10,570	11,689
30 Sep 23	50,044	9,901	11,354
30 Jun 23	47,807	11,708	10,201
31 Mar 23	45,626	11,035	9,863
31 Dec 22	42,799	9,763	10,066
30 Sep 22	41,143	9,437	9,753
30 Jun 22	39,976	6,310	8,699
31 Mar 22	39,366	6,051	8,729
31 Dec 21	37,978	5,510	8,230
30 Sep 21	36,193	4,516	7,797
30 Jun 21	32,486	3,236	6,514
31 Mar 21	25,080	-1,375	5,657
31 Dec 20	27,772	-1,177	2,199
30 Sep 20	22,487	-2,134	1,121
30 Jun 20	14,849	-2,681	-613
31 Mar 20	10,590	590	3,049
31 Dec 19	10,081	268	761
30 Sep 19	18,609	720	549
30 Jun 19	17,719	360	709
31 Mar 19	16,939	-30	759
30 Jun 18	17,053	-704	765
31 Mar 18	17,303	-302	838
31 Mar 17	16,085	-14	721
31 Mar 16	14,343	-180	698
31 Mar 15	7,896	-381	409
31 Mar 14	9,445	-646	132

質の高い収益: 543220は高品質の収益を持っています。

利益率の向上: 543220の現在の純利益率 (17.6%)は、昨年(19.8%)よりも低くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: 543220の収益は過去 5 年間で年間49.2%増加しました。

成長の加速: 543220の過去 1 年間の収益成長率 ( 7% ) は、5 年間の平均 ( 年間49.2%を下回っています。

収益対業界: 543220の過去 1 年間の収益成長率 ( 7% ) Healthcare業界29.6%を上回りませんでした。

株主資本利益率

高いROE: 543220の自己資本利益率 ( 12% ) は低いとみなされます。

Max Healthcare Institute 過去の業績

過去 基準チェック /26

主要情報

最近の業績更新

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q2, 2025 Results on Nov 06, 2024

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q1, 2025 Results on Aug 01, 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q4, 2024 Results on May 22, 2024

Recent updates

Consensus revenue estimates increase by 13%

Max Healthcare Institute Limited (BSE:543220) acquired remaining 36.35% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for INR 2.3 billion.

Price target increased by 8.2% to ₹1,017

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited Cessation of Gautam Wadhwa as Director

Max Healthcare Institute Limited (BSE:543220) completed the acquisition of 63.65% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for INR 4 billion.

Max Healthcare Institute Limited Appoints Kummamuri Narasimha Murthy as an Independent Director

Max Healthcare Institute Limited Announces Declaration of Final Dividend

Max Healthcare Institute Limited (BSE:543220) entered into a Strategic Collaboration Agreement to acquire 64% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for an enterprise value of INR 16.6 billion.

Insufficient new directors

Max Healthcare Institute Limited to Report Q2, 2025 Results on Nov 06, 2024

Upcoming dividend of ₹1.50 per share

Max Healthcare Institute Limited, Annual General Meeting, Sep 20, 2024

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q1, 2025 Results on Aug 01, 2024

Max Healthcare Institute Limited Recommends Final Dividend for the Financial Year 2023-24

Full year 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q4, 2024 Results on May 22, 2024

Max Healthcare Institute Limited (BSE:543220) agreed to acquire Alexis Multi-speciality Hospital Private Limited for approximately INR 3720 million.

Price target increased by 11% to ₹767

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Nine Months, 2024 Results on Jan 31, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q2, 2024 Results on Nov 06, 2023

Max Healthcare Institute Limited Approves the Declaration of Final Dividend for the Financial Year Ended March 31, 2023

Max Healthcare Institute Limited Announces Change in Management

Max Healthcare Institute Limited Provides Update on Petition Filed by the Company Against Touch Healthcare Private Limited and Others

Max Healthcare Institute Limited, Annual General Meeting, Sep 27, 2023

Max Healthcare Institute Limited Announces Appointment of Amrita Gangotra as Additional Director (Non-Executive and Independent Woman Director)

Price target increased by 7.1% to ₹611

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q1, 2024 Results on Aug 07, 2023

Aster Eye $300 million India Stake Sale

Price target increased by 8.1% to ₹564

Full year 2023 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q4, 2023 Results on May 16, 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 12%

Max Healthcare Institute Limited Announces Executive Changes

Max Healthcare Institute Limited to Report Q3, 2023 Results on Feb 02, 2023

Blackstone, CVC Manipal, Max Reportedly Eye KIMS Stake

Max Healthcare Reportedly Eyeing AMRI Hospitals

Price target increased to ₹512

Price target increased to ₹498

KKR, Temasek Reportedly Vie for Care Hospitals; Deal Likely at $1 Billion

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Max Healthcare Institute Limited Announces Management Changes

Max Healthcare Institute Limited to Report Q2, 2023 Results on Nov 01, 2022

Max Healthcare Institute Limited Announces Resignation of Ruchi Mahajan as Company Secretary and Compliance Officer

Max Healthcare Institute Limited Announces Cessation of Prashant Kumar as Non-Executive Non-Independent Director

Investor sentiment improved over the past week

Max Healthcare Institute Limited Announces Resignation of Gaurav Trehan as Non-Executive Non-Independent Director

KKR Reportedly Plans to Exit Max Healthcare by Selling its Entire 27.54% Stake

Max Healthcare Institute Limited, Annual General Meeting, Sep 26, 2022

High number of new directors

Max Healthcare Institute Limited to Report Q1, 2023 Results on Aug 10, 2022

KKR Affiliate Not in Talks for Stake Sale in Max Health

KKR Reportedly May Sell Stake in Max

Full year 2022 earnings: EPS and revenues miss analyst expectations

Ontario Teachers' Pension Plan Board, Max Healthcare Reportedly Lead the Race for Sahyadri Hospitals

Ontario Teachers' Pension Plan Board, Max Healthcare Reportedly Lead the Race for Sahyadri Hospitals

Max Healthcare Institute Limited to Report Q4, 2022 Results on May 25, 2022

High number of new and inexperienced directors

High number of new directors

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited Announces Executive Changes

Max Healthcare Institute Limited to Report Q3, 2022 Results on Feb 12, 2022

Consensus forecasts updated

Price target increased to ₹444

過去基準チェック /26